FTC Tries Pulling Teva Into Cephalon Pay-For-Delay Suit

Law360, New York (December 10, 2013, 5:49 PM EST) -- The Federal Trade Commission asked a Pennsylvania federal judge Monday to add Teva Pharmaceutical Industries Ltd. as a defendant in its antitrust suit over payments Provigil maker Cephalon Inc. made to block generic versions of its drug, citing Teva's acquisition of the company. 

The FTC clarified that it was not trying to drag Teva — the world's largest generic pharmaceutical company — into the lawsuit over money it received from Cephalon to abstain from producing a generic form of the narcolepsy drug, but only because the...
To view the full article, register now.